ENOV
Enovis Corp
NYSE: ENOV · HEALTHCARE · MEDICAL DEVICES
$23.44
+4.22% today
Updated 2026-04-30
Market cap
$1.35B
P/E ratio
—
P/S ratio
0.60x
EPS (TTM)
$-20.72
Dividend yield
—
52W range
$21 – $38
Volume
1.0M
Enovis Corp (ENOV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-52.70%
Operating margin
6.09%
ROE
-58.30%
ROA
1.09%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $393.60M | $94000.00 | 34.76% | 4.97% | 0.02% |
| 2007 | $506.31M | $64.88M | 34.68% | 24.35% | 12.81% |
| 2008 | $604.85M | $-571000.00 | 35.91% | 2.76% | -0.09% |
| 2009 | $525.02M | $21.72M | 35.39% | 7.33% | 4.14% |
| 2010 | $541.99M | $16.21M | 35.32% | 6.34% | 2.99% |
| 2011 | $693.39M | $4.55M | 34.63% | 3.74% | 0.66% |
| 2012 | $3.91B | $-64.40M | 29.44% | 3.58% | -1.65% |
| 2013 | $4.21B | $178.63M | 31.05% | 9.66% | 4.25% |
| 2014 | $4.62B | $392.10M | 31.98% | 8.86% | 8.48% |
| 2015 | $3.97B | $167.74M | 31.55% | 7.18% | 4.23% |
| 2016 | $3.65B | $128.11M | 31.41% | 6.53% | 3.51% |
| 2017 | $3.30B | $151.09M | 31.19% | 0.88% | 4.58% |
| 2018 | $2.19B | $140.20M | 33.26% | 6.91% | 6.39% |
| 2019 | $3.33B | $-527.65M | 42.11% | 6.12% | -15.86% |
| 2020 | $3.07B | $42.63M | 41.95% | 5.29% | 1.39% |
| 2021 | $1.43B | $71.66M | 54.53% | -4.40% | 5.02% |
| 2022 | $1.56B | $-13.29M | 55.62% | -4.55% | -0.85% |
| 2023 | $1.71B | $-33.26M | 58.04% | -3.85% | -1.95% |
| 2024 | $2.11B | $-825.49M | 56.02% | -36.81% | -39.17% |
| 2025 | $2.25B | $-1.18B | 59.84% | -52.57% | -52.69% |